Increased anxiogenic effects of caffeine in panic disorders.
about
Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptorsCan Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.Do initial responses to drugs predict future use or abuse?Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma.Serotonin function in anxietyADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.Equine poisoning by coffee husk (Coffea arabica L.).The modification of breathing behavior. Pavlovian and operant control in emotion and cognition.Caffeine challenge test and panic disorder: a systematic literature review.Genetics of caffeine consumption and responses to caffeine.Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.Cerebral blood flow and metabolism in anxiety and anxiety disordersComplementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illnessDose-dependent pharmacokinetics and psychomotor effects of caffeine in humans.Cognitive enhancers for anxiety disorders.Theoretical and therapeutic considerations for the anxiety disorders.Neurobiology of panic and pH chemosensation in the brain.Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.Panic disorder. Recognizing and managing the 'real thing'.Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects.Does the panic attack activate the hypothalamic-pituitary-adrenal axis?Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school childrenEffect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responsesManagement of panic disorders.Respiratory patterns in panic disorder reviewed: a focus on biological challenge tests.Advances in molecular genetics of panic disorder.Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.Emerging drugs for panic disorder.Adenosine antagonists.The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder.Medical disorders in the schizophrenic patient.Substance use disorder: abuse, dependence and dyscontrol.Anxiolytic activity of adenosine receptor activation in mice.Caffeine-induced behavioural stimulation is dose- and concentration-dependentCaffeine consumption among eating disorder patients: epidemiology, motivations, and potential of abuse.Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA.Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.
P2860
Q24657796-8E022EF7-4A93-4A36-A03A-7B358FE6D098Q24675108-D1E34DEF-ABAB-4AAD-8A94-6FC566CAC93BQ26738449-1726E804-EEB9-4AF2-B0A8-3C58A1D3EF21Q27022602-5069D44B-6C29-4C86-8A60-5F39852CF280Q27025975-A67ADA8A-889E-450F-85F9-52E7F19D8B92Q28728111-93D644FE-A451-46C7-A380-60C9B77AB83BQ30051329-ABA576E6-E90B-4CFF-9AC9-CE5A02A8434AQ30458759-602DBEBD-9002-487D-AFA9-99D2517747BDQ30512463-7FF17685-B244-4E9E-A168-A1C4A381EF01Q33723022-F28B93D6-1D27-4D82-9AAF-C42545D5F4D1Q34027885-79CD103A-8B93-4F0A-8FBA-3B52E4343FA0Q34119748-3982CCB7-6A08-4D86-A929-793D468CB3C6Q34125945-B75F35F8-2E05-40C7-8FC1-0AF513B4B4D1Q34274613-679FF554-BBAF-4D49-B70C-E7C33D7998A1Q34411930-22D74BF2-2C92-4F29-9E41-AFEB502AFF49Q34615473-EE794383-BB8E-48A9-8B28-0F8B238D06CEQ34743637-718355D1-1442-4D32-8CFB-FADBCFC1FD25Q35043125-03635D0B-9196-425E-A360-F6E654C7D351Q35274922-ECD62953-E726-4882-B01A-7417B1E857FEQ35686869-6C72672E-8B3C-4C14-94C1-62E879BBAD70Q35827223-EB2E2811-1912-456C-A59F-769B1BBDA746Q36127525-330931E0-966B-4B99-BCDD-F6D69210A16BQ36237747-36C32177-5A64-4B05-9723-5AC3FD516B9FQ36243043-EE239729-0C77-468C-B56E-1FF59BECD0E6Q36344520-0B7A46DC-22B9-4D44-BAA8-1F62831936DCQ36534245-D0543C91-427B-48EA-ACB4-BF1F882BB2B7Q37042373-7D11900A-1A10-4E85-BA8F-7C2059375827Q37528558-467F706E-FE2E-4FC0-AAA6-6CBA783D4ACFQ37667843-3B295A65-93CC-4C87-A247-9352A1BB32EEQ37686937-5797AE2F-8620-460F-AD68-EC26C221EE06Q37945699-7CC4B364-8E39-4812-8EB0-0BE98B713558Q38627149-06B19EA8-F166-4C91-A2EE-B801286CAFCCQ38940622-4E401EC0-C0BA-4B7D-8D25-F739CFB5228AQ40433554-D8F34388-1629-4402-B4D2-66EDE805B419Q40748385-9747C834-2D05-44F2-AEE7-DDAC509FE620Q41771392-56C24E99-1EA1-4BD5-A4BE-54BF8FD32127Q42562226-FC100075-4352-4721-A5BF-716BD43808FAQ43152432-967C0DCA-F53F-45EB-A273-D542873EB6C0Q43621768-5D3D6EFF-C7BE-4DDD-B448-AAD9A618D706Q44490447-991A2FC8-6DA8-4472-BA06-92CBB70CF307
P2860
Increased anxiogenic effects of caffeine in panic disorders.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Increased anxiogenic effects of caffeine in panic disorders.
@en
Increased anxiogenic effects of caffeine in panic disorders.
@nl
type
label
Increased anxiogenic effects of caffeine in panic disorders.
@en
Increased anxiogenic effects of caffeine in panic disorders.
@nl
prefLabel
Increased anxiogenic effects of caffeine in panic disorders.
@en
Increased anxiogenic effects of caffeine in panic disorders.
@nl
P2093
P1433
P1476
Increased anxiogenic effects of caffeine in panic disorders.
@en
P2093
Charney DS
Heninger GR
P304
P356
10.1001/ARCHPSYC.1985.01790260027003
P407
P577
1985-03-01T00:00:00Z